ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1AChris T. Williamson, Christopher J. Lord, Rachel Brough et al.|Nature Communications|2016Cited by 386
Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor SensitivityIlirjana Bajrami, Alan Ashworth, Jessica Frankum et al.|Cancer Research|2013Cited by 367
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Christopher J. Lord, Colm J. Ryan et al.|Cell Reports|2016Cited by 109
Synthetic Lethal Targeting of <i>ARID1A</i> -Mutant Ovarian Clear Cell Tumors with DasatinibRowan Miller, Alan Ashworth, Rachel Brough et al.|Molecular Cancer Therapeutics|2016Cited by 85